Testing patients for specific biomarkers is integral to precision medicine in cancer care, but many patients who could benefit from this type of testing aren't getting it. Your story could help change that.
Join ACS CAN in calling on Connecticut lawmakers to require appropriate coverage of biomarker testing for public and private insurance plans.
You have the passion to help end suffering and death from cancer. We have the tools and camaraderie to help make you wildly successful.
